Young, a veteran of hospital administration since 1985, most recently served as president and CEO of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corp. of America.
Prior to her appointment to the Denver-based Division headquarters, Young served as president of HCA's Sunrise Health System, including Sunrise Hospital and Medical Center, Sunrise Children's Hospital, MountainView Hospital and Southern Hills Hospital, as well as four ambulatory surgery centers in Las Vegas, NV. Young retired from HCA in March 2023.
In 2022, Young was named one of "2022 Top Women to Watch in Healthcare" by Modern Healthcare Magazine.
She currently serves as an independent director on the board of Lincoln Educational Services Corp.
Pediatrix Medical Group, Inc. (NYSE: MD) is the nation's provider of physician services.
Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices.
Specialties include obstetrics, maternal-fetal medicine and neonatology complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics.
The physician-led company was founded in 1979 as a single neonatology practice and TODAY provides its highly specialized and often critical care services through more than 5,000 affiliated physicians and other clinicians in 37 states.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer